share_log

Encision Inc. (OTCMKTS:ECIA) Short Interest Update

Financial News Live ·  Dec 15, 2022 00:41

Encision Inc. (OTCMKTS:ECIA – Get Rating) was the target of a large drop in short interest in November. As of November 30th, there was short interest totalling 500 shares, a drop of 66.7% from the November 15th total of 1,500 shares. Based on an average daily trading volume, of 9,400 shares, the short-interest ratio is presently 0.1 days.

Encision Stock Down 6.0 %

Shares of OTCMKTS:ECIA traded down $0.03 during trading on Wednesday, reaching $0.47. The stock had a trading volume of 10,100 shares, compared to its average volume of 5,544. Encision has a one year low of $0.39 and a one year high of $1.49. The company has a market capitalization of $5.53 million, a P/E ratio of -15.67 and a beta of 0.31. The company has a current ratio of 2.99, a quick ratio of 1.34 and a debt-to-equity ratio of 0.11. The firm's 50-day simple moving average is $0.49 and its 200 day simple moving average is $0.53.

Get Encision alerts:

About Encision

(Get Rating)

Encision Inc, a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures.

See Also

  • Get a free copy of the StockNews.com research report on Encision (ECIA)
  • Mullen Automotive Shares Jump After Signing New Partner
  • REV Group Leads Specialty Vehicle Manufacturers Higher
  • NVIDIA vs AMD: Which is better for 2023?
  • Can FDA Approval Bolster DexCom, Inc.?
  • Harpoon Therapeutics Remains Volatile After Promising News

Receive News & Ratings for Encision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encision and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment